XML 22 R6.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - UNAUDITED - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Adjustments due to adoption of new accounting standards
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Accumulated Earnings
Accumulated Earnings
Adjustments due to adoption of new accounting standards
Noncontrolling Interest
Balance, beginning of period, shares at Dec. 31, 2021   32,495,000              
Balance, beginning of period at Dec. 31, 2021 $ 440,244 $ 705 $ 488,303   $ (930,106) $ (38,353) $ 916,060   $ 3,635
Net income             6,113    
Unrealized gain (loss) on short-term investments, net of tax           (2)      
Foreign currency translation adjustments           (1,182)      
Total comprehensive income (loss) 4,929                
Repurchase of common stock (23,801) $ (1) (7,804)   (15,996)        
Repurchase of common stock, shares   (389,000)              
Issuance of common stock pursuant to employee stock purchase plan 650   650            
Issuance of common stock pursuant to employee stock purchase plan, shares   12,000              
Issuance of restricted common stock pursuant to stock-based compensation plans   $ 5 (5)            
Issuance of restricted common stock pursuant to stock-based compensation plans, shares   476,000              
Cancellation of restricted common stock issued pursuant to stock-based compensation plans, shares   (34,000)              
Stock-based compensation expense 5,581   5,581            
Settlement of convertible debt securities, net of tax (4,845)   (4,845)            
Dividends (8,586)           (8,586)    
Balance, ending of period, shares at Mar. 31, 2022   32,560,000              
Balance, ending of period at Mar. 31, 2022 414,172 $ 709 472,078 $ (9,802) (946,102) (39,537) 923,389 $ 9,802 3,635
Balance, beginning of period, shares at Dec. 31, 2021   32,495,000              
Balance, beginning of period at Dec. 31, 2021 440,244 $ 705 488,303   (930,106) (38,353) 916,060   3,635
Net income 11,430                
Unrealized gain (loss) on short-term investments, net of tax 3                
Foreign currency translation adjustments (17,182)                
Total comprehensive income (loss) (5,749)                
Balance, ending of period, shares at Jun. 30, 2022   32,195              
Balance, ending of period at Jun. 30, 2022 377,022 $ 709 479,271   (967,659) (55,532) 920,233    
Balance, beginning of period, shares at Mar. 31, 2022   32,560,000              
Balance, beginning of period at Mar. 31, 2022 414,172 $ 709 472,078 $ (9,802) (946,102) (39,537) 923,389 $ 9,802 3,635
Net income 5,317           5,317    
Unrealized gain (loss) on short-term investments, net of tax 5         (5)      
Foreign currency translation adjustments (16,000)         (16,000)      
Total comprehensive income (loss) (10,678)                
Repurchase of common stock 21,673   (116)   (21,557)        
Repurchase of common stock, shares   (362,000)              
Issuance of common stock pursuant to employee stock purchase plan 773   773            
Issuance of common stock pursuant to employee stock purchase plan, shares   15,000              
Issuance of restricted common stock pursuant to stock-based compensation plans   $ 1 (1)            
Issuance of restricted common stock pursuant to stock-based compensation plans, shares   42,000              
Cancellation of restricted common stock issued pursuant to stock-based compensation plans   $ (1) 1            
Cancellation of restricted common stock issued pursuant to stock-based compensation plans, shares   (60,000)              
Stock-based compensation expense 6,536   6,536            
Dividends (8,473)           (8,473)    
Write-off of noncontrolling interest (3,635)               $ (3,635)
Balance, ending of period, shares at Jun. 30, 2022   32,195              
Balance, ending of period at Jun. 30, 2022 $ 377,022 $ 709 479,271   (967,659) (55,532) 920,233    
Balance, beginning of period, shares at Dec. 31, 2022 31,269,000 31,269              
Balance, beginning of period at Dec. 31, 2022 $ 355,249 $ 708 495,189   (1,018,034) (58,829) 936,215    
Net income             20,928    
Foreign currency translation adjustments           2,843      
Total comprehensive income (loss) 23,771                
Repurchase of common stock (9,306) $ (2) (9,304)            
Repurchase of common stock, shares   (166)              
Issuance of common stock pursuant to employee stock purchase plan 893   893            
Issuance of common stock pursuant to employee stock purchase plan, shares   19              
Issuance of restricted common stock pursuant to stock-based compensation plans   $ 6 (6)            
Issuance of restricted common stock pursuant to stock-based compensation plans, shares   574              
Cancellation of restricted common stock issued pursuant to stock-based compensation plans, shares   (18,000)              
Stock-based compensation expense 6,412   6,412            
Dividends (8,796)           (8,796)    
Balance, ending of period, shares at Mar. 31, 2023   31,678,000              
Balance, ending of period at Mar. 31, 2023 $ 368,223 $ 712 493,184   (1,018,034) 55,986 948,347    
Balance, beginning of period, shares at Dec. 31, 2022 31,269,000 31,269              
Balance, beginning of period at Dec. 31, 2022 $ 355,249 $ 708 495,189   (1,018,034) (58,829) 936,215    
Net income 34,882                
Unrealized gain (loss) on short-term investments, net of tax 0                
Foreign currency translation adjustments 4,552                
Total comprehensive income (loss) $ 39,434                
Balance, ending of period, shares at Jun. 30, 2023 31,751,000 31,751              
Balance, ending of period at Jun. 30, 2023 $ 383,311 $ 713 501,486   (1,018,034) (54,277) 953,423    
Balance, beginning of period, shares at Mar. 31, 2023   31,678,000              
Balance, beginning of period at Mar. 31, 2023 368,223 $ 712 493,184   (1,018,034) 55,986 948,347    
Net income 13,954           13,954    
Unrealized gain (loss) on short-term investments, net of tax 0                
Foreign currency translation adjustments 1,709         1,709      
Total comprehensive income (loss) 15,663                
Repurchase of common stock (112)   (112)            
Repurchase of common stock, shares   (2)              
Issuance of common stock pursuant to employee stock purchase plan 771   771            
Issuance of common stock pursuant to employee stock purchase plan, shares   18              
Issuance of restricted common stock pursuant to stock-based compensation plans   $ 1 (1)            
Issuance of restricted common stock pursuant to stock-based compensation plans, shares   64              
Cancellation of restricted common stock issued pursuant to stock-based compensation plans, shares   (7,000)              
Stock-based compensation expense 7,644   7,644            
Dividends $ (8,878)           (8,878)    
Balance, ending of period, shares at Jun. 30, 2023 31,751,000 31,751              
Balance, ending of period at Jun. 30, 2023 $ 383,311 $ 713 $ 501,486   $ (1,018,034) $ (54,277) $ 953,423